DNABW (Ginkgo Bioworks Holdings) Other Current Receivables: $0.45 Mil (As of Mar. 2026)


DNABW Ginkgo Bioworks Holdings Inc DNABW
63 GF Score
Price $0.00
! 6 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Other Current Receivables?

Ginkgo Bioworks Holdings DNABW 63 Other Current Receivables is $0.45 Mil as of Mar. 2026. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 6 warning signs investors should review.

Ginkgo Bioworks Holdings's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.45 Mil.

Ginkgo Bioworks Holdings's quarterly Other Current Receivables declined from Sep. 2025 ($0.93 Mil) to Dec. 2025 ($0.23 Mil) but then increased from Dec. 2025 ($0.23 Mil) to Mar. 2026 ($0.45 Mil).

Ginkgo Bioworks Holdings's annual Other Current Receivables declined from Dec. 2023 ($0.74 Mil) to Dec. 2024 ($0.59 Mil) and declined from Dec. 2024 ($0.59 Mil) to Dec. 2025 ($0.23 Mil).

Ginkgo Bioworks Holdings Other Current Receivables Related Terms

Ginkgo Bioworks Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings Other Current Receivables Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 6.80 1.56 0.74 0.59 0.23

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.97 0.93 0.23 0.45
DNABW
63GF Score
Ginkgo Bioworks Holdings Inc DNABW
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.45 Mil mean?
Ginkgo Bioworks Holdings (DNABW) has a Other Current Receivables of $0.45 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ginkgo Bioworks Holdings and its competitors.
Is Ginkgo Bioworks Holdings' Other Current Receivables too high?
Ginkgo Bioworks Holdings' current Other Current Receivables is $0.45 Mil. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Other Current Receivables compare to AGMB and ACRS?
Ginkgo Bioworks Holdings' Other Current Receivables of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current Other Current Receivables is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Other Current Receivables of $0.45 Mil. The current Other Current Receivables is $0.45 Mil. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Other Current Receivables is $0.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score

Get the complete analysis for DNABW

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price